Published in Liver Transpl on October 01, 2004
Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review. World J Gastroenterol (2009) 1.22
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant (2010) 1.05
Inflammation and repair in viral hepatitis C. Dig Dis Sci (2008) 0.94
Barriers preventing liver transplantation in Canadians with HIV-infection--perceptions of HIV specialists. Can J Gastroenterol (2007) 0.84
Strategies to reduce hepatitis C virus recurrence after liver transplantation. World J Hepatol (2013) 0.82
Fatal lactic acidosis in a kidney transplant recipient on combination antiretroviral therapy after initiation of tacrolimus therapy. Case Rep Transplant (2012) 0.81
Liver transplantation trends in the HIV population. Dig Dis Sci (2011) 0.79
Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany. AIDS Res Treat (2012) 0.77
Impact of new treatment options for hepatitis C virus infection in liver transplantation. World J Gastroenterol (2015) 0.77
Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART). PLoS One (2015) 0.76
Pros and cons of liver transplantation in human immunodeficiency virus infected recipients. World J Gastroenterol (2014) 0.76
Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus. World J Hepatol (2013) 0.76
Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World J Gastroenterol (2014) 0.76
Liver transplantation in HCV/HIV positive patients. World J Gastrointest Surg (2011) 0.76
Solid organ transplantation and HIV: A changing paradigm. Can J Infect Dis Med Microbiol (2008) 0.75
Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience. Eur J Med Res (2011) 0.75
Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2010) 0.75
Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan. Surg Today (2011) 0.75
The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol (2008) 31.04
PRIDE: the proteomics identifications database. Proteomics (2005) 7.52
The MGED Ontology: a resource for semantics-based description of microarray experiments. Bioinformatics (2006) 7.37
ISA software suite: supporting standards-compliant experimental annotation and enabling curation at the community level. Bioinformatics (2010) 5.60
Toward interoperable bioscience data. Nat Genet (2012) 4.72
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?". OMICS (2008) 4.15
Development of FuGO: an ontology for functional genomics investigations. OMICS (2006) 3.59
Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology (2008) 2.98
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91
IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol (2004) 2.81
Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81
Establishing reporting standards for metabolomic and metabonomic studies: a call for participation. OMICS (2006) 2.72
RDML: structured language and reporting guidelines for real-time quantitative PCR data. Nucleic Acids Res (2009) 2.72
Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl (2007) 2.59
The metabolomics standards initiative. Nat Biotechnol (2007) 2.54
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17
Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol (2003) 2.05
Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl (2013) 2.05
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01
Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97
Towards BioDBcore: a community-defined information specification for biological databases. Nucleic Acids Res (2010) 1.97
Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83
Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl (2006) 1.82
Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology (2006) 1.80
Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology (2009) 1.77
Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol (2011) 1.74
One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62
Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60
Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58
Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol (2006) 1.58
Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency. Gastroenterology (2013) 1.57
InvertNet: a new paradigm for digital access to invertebrate collections. Zookeys (2012) 1.50
Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl (2013) 1.48
Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47
Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47
Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47
Meeting Report: BioSharing at ISMB 2010. Stand Genomic Sci (2010) 1.47
Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45
Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45
Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45
Diaphragmatic dysfunction after pediatric orthotopic liver transplantation. Transplantation (2002) 1.43
Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
Live organ-donation for islet transplantation. Lancet (2005) 1.40
Cystic biliary atresia: an etiologic and prognostic subgroup. J Pediatr Surg (2008) 1.40
Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg (2004) 1.39
Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project. Proteomics (2005) 1.37
Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop. Stand Genomic Sci (2010) 1.35
QTL mapping of vernalization response in perennial ryegrass (Lolium perenne L.) reveals co-location with an orthologue of wheat VRN1. Theor Appl Genet (2004) 1.32
Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25
Towards BioDBcore: a community-defined information specification for biological databases. Database (Oxford) (2011) 1.24
Mutations in TTC37 cause trichohepatoenteric syndrome (phenotypic diarrhea of infancy). Gastroenterology (2010) 1.20
Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18
The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15
Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Transplantation (2015) 1.13
Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13
Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency. J Pediatr Gastroenterol Nutr (2010) 1.12
Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12
Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol (2007) 1.12
Autumn 2005 Workshop of the Human Proteome Organisation Proteomics Standards Initiative (HUPO-PSI) Geneva, September, 4-6, 2005. Proteomics (2006) 1.11
Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem (2005) 1.11
Pseudoaneurysm following laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2007) 1.10
Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10
Emergency liver transplantation following severe liver trauma. Liver Transpl (2008) 1.09
Genetic diversity and genomic distribution of homologs encoding NBS-LRR disease resistance proteins in sunflower. Mol Genet Genomics (2008) 1.09
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08
Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int (2007) 1.08
Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab. Liver Transpl (2005) 1.08
Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary Pancreat Dis Int (2010) 1.07
The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation (2004) 1.07
How we treat sickle hepatopathy and liver transplantation in adults. Blood (2014) 1.07
Cholangiopathy and the biliary cast syndrome. Eur J Gastroenterol Hepatol (2003) 1.06
Liver transplantation for hepatocellular carcinoma with allografts from donors after circulatory death: is the tumor recurrence genuinely increased? Liver Transpl (2014) 1.06
Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation (2003) 1.06
Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons. Sex Transm Dis (2006) 1.03